EGFR and rheumatoid arthritis: In cluster 1, the major drug-related genes included CXCR4, EGFR, and LAMA2. Targeting the inhibition of CXCR4 and EGFR may be crucial directions to suppress the aberrant pathological behavior of RA FLS and angiogenesis.